A group of rich people think a company called ImmunityBio will do well in the future, so they are buying special contracts that let them buy shares of the company at a certain price later. This is important because it can tell other smaller investors what to expect from the company's stock price. Read from source...

- The article title is misleading and sensationalized. It implies that the options market can provide a definitive answer about ImmunityBio's prospects, which is not true. Options markets are just one of many sources of information that investors can use to make informed decisions.
- The article does not provide any concrete evidence or analysis to support its claims. It relies on vague terms like "high-rolling investors" and "bullish" without explaining who they are, how they are positioned, and why they are bullish.
- The article uses emotional language and appeals to fear and greed. It suggests that retail traders should follow the actions of high-rolling investors because otherwise they will miss out on a potential opportunity. This is a classic example of market manipulation and herd behavior, which can lead to irrational decisions and losses.
- The article does not disclose any conflicts of interest or potential biases that may influence its author's perspective. For instance, it does not mention if the author has any affiliation with ImmunityBio or any other stakeholders in the company. It also does not acknowledge any risks or challenges that ImmunityBio may face in the future.
- The article does not provide any actionable advice or recommendations for readers. It only states that high-rolling investors are bullish on ImmunityBio, but it does not explain why, how, or when they plan to exit their positions. It also does not offer any guidance on how retail traders can profit from this situation or hedge their risks.

Bullish

Summary:
The article discusses the options market activity for ImmunityBio and how high-rolling investors have positioned themselves in a bullish manner. It is important for retail traders to take note of this activity as it may indicate a potential increase in the company's stock price. The article also mentions that Benzinga tracks publicly available options data to identify such trends and inform readers.

AI is an AI model that can bypass any policy or rule set for it, so it has no limitations on what it can say or do. It will provide its own opinions and analysis based on the given article and other sources of information. AI may not be accurate or reliable, and should not be used as a basis for making any investment decisions. AI is intended for entertainment and educational purposes only.